[Focus on the Odon Device™: Technical improvements, mechanical principles and progress of the clinical research program].

Mise au point sur l’Odon Device™ : amélioration technique, fonctionnement et avancée du programme de recherche clinique.
Accouchement instrumental Assisted delivery Innovation Mecanique obstétricale Obstetrical mecanics Recherche Research

Journal

Gynecologie, obstetrique, fertilite & senologie
ISSN: 2468-7189
Titre abrégé: Gynecol Obstet Fertil Senol
Pays: France
ID NLM: 101693805

Informations de publication

Date de publication:
11 2020
Historique:
received: 30 10 2019
pubmed: 19 3 2020
medline: 25 11 2021
entrez: 19 3 2020
Statut: ppublish

Résumé

The Odon Device™ has been described in the literature since 2013 and the World Health Organization supports its development through the Human Reproduction Program. This innovative device could be easier to use than usual instruments and could be an alternative to caesarean section during the second stage of labor, especially in countries where access to obstetric care is limited. The aim of the Odon Device™ is to position an air cuff over the fetal head, past its widest point (around the level of the fetal mouth anteriorly and the nape of the fetal neck posteriorly). Three mechanical principles favor the progression of the fetal head with the Odon Device™: partial propulsion, limited flexion and traction. Preliminary clinical studies on animals and simulators are reassuring and show that an appropriate use is no more at risk than the vaccum or forceps. A phase 1 study was conducted in Argentina and South Africa between 2011 and 2017. The reported failure rate was 29%, of which 77% was secondary to a mechanical failure of one of the components of the device. Improvements concerning the applicator, the handles and the inflatable air cuff have been made to the device. Phase II of the clinical research program began in 2018 and includes two studies in two different centers: The ASSIST Study in Bristol, England, and The BESANCON ASSIST Study, Besançon, France.

Identifiants

pubmed: 32184177
pii: S2468-7189(20)30107-0
doi: 10.1016/j.gofs.2020.03.011
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

814-819

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

N Mottet (N)

Service de gynécologie-obstétrique, centre hospitalo-universitaire de Besançon, université de Franche-Comté, 25000 Besançon, France. Electronic address: ncmottet@gmail.com.

A Bourtembourg (A)

Service de gynécologie-obstétrique, centre hospitalo-universitaire de Besançon, université de Franche-Comté, 25000 Besançon, France.

A Eckman-Lacroix (A)

Service de gynécologie-obstétrique, centre hospitalo-universitaire de Besançon, université de Franche-Comté, 25000 Besançon, France.

O Forner (O)

Service de gynécologie-obstétrique, centre hospitalo-universitaire de Besançon, université de Franche-Comté, 25000 Besançon, France; Nanomedicine Lab, Imagery and Therapeutics, EA4662, University of Franche-Comte, 25000 Besançon, France.

C Mougey (C)

Service de pédiatrie et de réanimation pédiatrique, centre hospitalo-universitaire de Besançon, université de Franche-Comté, 25000 Besançon, France.

J P Metz (JP)

Service de gynécologie-obstétrique, centre hospitalo-universitaire de Besançon, université de Franche-Comté, 25000 Besançon, France.

R Ramanah (R)

Service de gynécologie-obstétrique, centre hospitalo-universitaire de Besançon, université de Franche-Comté, 25000 Besançon, France.

D Riethmuller (D)

Service de gynécologie-obstétrique, centre hospitalo-universitaire de Besançon, université de Franche-Comté, 25000 Besançon, France; Service de gynécologie-obstétrique, centre hospitalo-universitaire de Grenoble, 38000 Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH